Cargando…
The effectiveness gap in COPD: a mixed methods international comparative study
BACKGROUND: There has been a large increase in treatment and in research on chronic obstructive pulmonary disease (COPD) from the common starting point of the original Global Initiative for Chronic Obstructive Lung Disease (GOLD) study. There is currently little evidence on the degree of similarity...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442783/ https://www.ncbi.nlm.nih.gov/pubmed/23549383 http://dx.doi.org/10.4104/pcrj.2013.00035 |
_version_ | 1783407757226934272 |
---|---|
author | Bosanquet, Nick Dean, Lucy Iordachescu, Irina Sheehy, Colm |
author_facet | Bosanquet, Nick Dean, Lucy Iordachescu, Irina Sheehy, Colm |
author_sort | Bosanquet, Nick |
collection | PubMed |
description | BACKGROUND: There has been a large increase in treatment and in research on chronic obstructive pulmonary disease (COPD) from the common starting point of the original Global Initiative for Chronic Obstructive Lung Disease (GOLD) study. There is currently little evidence on the degree of similarity and difference between national programmes or on the linkage between research and policy. AIMS: To review the evidence on programme development and the effectiveness gap from the UK, France, Germany, and Finland. METHODS: Visits and literature reviews were undertaken for regional centres in Lancashire, Nord-Pas de Calais, and Finland, Eurostat data on mortality and hospital discharges were analysed, and telephone interviews were conducted in Nord-Rhein Westphalia. RESULTS: There have been very significant differences in programme development from the original GOLD starting point. The UK has national strategies but they are without consistent local delivery. The French Affection de Longue Durée (ALD) programme limits special help to at most 10% of patients and there is little use of spirometry in primary care. Germany has a more general Disease Management Programme with COPD as a late starter. Finland has had a successful 10-year programme. The results for the effectiveness gap on hospital discharges show a major difference between Finland (40.7% fall in discharges) and others (increases of 6.0–43.7%). CONCLUSIONS: The results show the need for a simpler programme in primary care to close the effectiveness gap. Such a programme is outlined based on preventing the downward spiral for high-risk patients. |
format | Online Article Text |
id | pubmed-6442783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-64427832019-07-01 The effectiveness gap in COPD: a mixed methods international comparative study Bosanquet, Nick Dean, Lucy Iordachescu, Irina Sheehy, Colm Prim Care Respir J Research Paper BACKGROUND: There has been a large increase in treatment and in research on chronic obstructive pulmonary disease (COPD) from the common starting point of the original Global Initiative for Chronic Obstructive Lung Disease (GOLD) study. There is currently little evidence on the degree of similarity and difference between national programmes or on the linkage between research and policy. AIMS: To review the evidence on programme development and the effectiveness gap from the UK, France, Germany, and Finland. METHODS: Visits and literature reviews were undertaken for regional centres in Lancashire, Nord-Pas de Calais, and Finland, Eurostat data on mortality and hospital discharges were analysed, and telephone interviews were conducted in Nord-Rhein Westphalia. RESULTS: There have been very significant differences in programme development from the original GOLD starting point. The UK has national strategies but they are without consistent local delivery. The French Affection de Longue Durée (ALD) programme limits special help to at most 10% of patients and there is little use of spirometry in primary care. Germany has a more general Disease Management Programme with COPD as a late starter. Finland has had a successful 10-year programme. The results for the effectiveness gap on hospital discharges show a major difference between Finland (40.7% fall in discharges) and others (increases of 6.0–43.7%). CONCLUSIONS: The results show the need for a simpler programme in primary care to close the effectiveness gap. Such a programme is outlined based on preventing the downward spiral for high-risk patients. Nature Publishing Group 2013-06 2013-04-02 /pmc/articles/PMC6442783/ /pubmed/23549383 http://dx.doi.org/10.4104/pcrj.2013.00035 Text en Copyright © 2013 Primary Care Respiratory Society UK |
spellingShingle | Research Paper Bosanquet, Nick Dean, Lucy Iordachescu, Irina Sheehy, Colm The effectiveness gap in COPD: a mixed methods international comparative study |
title | The effectiveness gap in COPD: a mixed methods international comparative study |
title_full | The effectiveness gap in COPD: a mixed methods international comparative study |
title_fullStr | The effectiveness gap in COPD: a mixed methods international comparative study |
title_full_unstemmed | The effectiveness gap in COPD: a mixed methods international comparative study |
title_short | The effectiveness gap in COPD: a mixed methods international comparative study |
title_sort | effectiveness gap in copd: a mixed methods international comparative study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442783/ https://www.ncbi.nlm.nih.gov/pubmed/23549383 http://dx.doi.org/10.4104/pcrj.2013.00035 |
work_keys_str_mv | AT bosanquetnick theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy AT deanlucy theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy AT iordachescuirina theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy AT sheehycolm theeffectivenessgapincopdamixedmethodsinternationalcomparativestudy AT bosanquetnick effectivenessgapincopdamixedmethodsinternationalcomparativestudy AT deanlucy effectivenessgapincopdamixedmethodsinternationalcomparativestudy AT iordachescuirina effectivenessgapincopdamixedmethodsinternationalcomparativestudy AT sheehycolm effectivenessgapincopdamixedmethodsinternationalcomparativestudy |